Dance-Based Exercise vs Clinical Pilates for Women with Overweight or Obesity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two-arm, parallel-group feasibility trial comparing a dance-based exercise program to a Clinical Pilates program in women aged 18-60 with BMI 25-35 kg/m². Participants are randomized to one of the two group-based, face-to-face interventions conducted at Pamukkale University. The study uses an assessor-blinded design and focuses on adherence, acceptability, enjoyment, quality of life, activity levels, body measurements, and physical performance. The trial applies concepts from Self-Determination Theory and the Theoretical Framework of Acceptability to gauge feasibility and potential for broader implementation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Female gender
* Aged 18 to 60 years
* Body Mass Index (BMI) between 25 and 35 kg/m²
* Clinically stable
* Able to participate regularly in the exercise program
* Volunteering to participate and providing written informed consent

Exclusion Criteria:

* Being pregnant or breastfeeding
* Currently on an active weight loss diet
* Receiving pharmacological treatment for obesity
* History of bariatric surgery
* Uncontrolled hypertension, uncontrolled diabetes, unstable cardiac disease, or serious cardiovascular risk for exercise
* Chronic respiratory system disease significantly affecting exercise tolerance
* Cancer, cerebrovascular disease, or severe systemic disease preventing safe exercise
* Musculoskeletal injury, neurological disease, or significant balance/vestibular/visual problems affecting exercise participation
* Uncontrolled psychiatric illness
* Acute infection
* Participating in a structured exercise program within the last 6 months
* Transport, time, or health barriers preventing regular attendance

Where it's running

• Pamukkale University Faculty of Physical Therapy and Rehabilitation
  Denizli, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Ummuhan Baş Aslan, Prof.
• Email: umbaslan@pau.edu.tr
• Phone: +902582964295

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

• EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes

  This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.

  Recruiting Phase 3 Eli Lilly and Company · Tucson, Arizona and 74 other locations · NCT07881458

• Monthly dose of PF-08653944 vs placebo in Chinese adults who are overweight or obese

  This study tests whether berobenatide (PF-08653944) given once a month helps adults in China lose weight compared with a placebo.

  Recruiting Phase 3 Pfizer · Hefei, Anhui and 5 other locations · NCT07874633

• FutureShape Family: a family-based weight-management program with semaglutide for children and parents

  This trial tests whether a family-centered program that combines a prescription medication (semaglutide) with lifestyle support and app-based coaching can help adults with obesity and their children who are overweight/obese.

  Recruiting Phase 4 University of Copenhagen · Copenhagen · NCT07872904

• Home self-administration of a weight-management medicine with an autoinjector in adults who are overweight or obese

  This study tests whether adults who are overweight or have obesity can successfully self-administer maridebart cafraglutide at home using an autoinjector.

  Recruiting at 25 sites Phase 3 Amgen · San Diego, California and 24 other locations · NCT07871409

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.